Shares of CBRE Group Inc (CBRE) have risen to $91.07, exceeding the average analyst 12-month target price of $89.83. Analysts are now faced with the decision to either downgrade their valuation or adjust the target price higher, influenced by recent positive trends in the company’s fundamentals.
Within Zacks’ coverage, the average target price derives from six analysts, with estimates ranging from $85 to $98. The standard deviation among these estimates is $5.564, indicating varied outlooks. Current analyst ratings reveal 4 strong buys, 3 holds, and no sell ratings, with the average rating at 1.86, where lower values indicate more favorable views.
